A Market Place Research – Page 2695

Japan Cosmetic Lasers Market 2022 driven by the considerable surge in the preference for non-aesthetic procedures

According to a new report published by Allied Market Research, titled, “Cosmetic Lasers Market by Product, Modality, Application and End-User: Global Opportunity Analysis and Industry Forecast, 2018–2026,” the cosmetic laser market size is expected to reach $5,416.70 million by 2026, registering a CAGR of 14.5% from 2019 to 2026, in terms of value

Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/5329

Key Findings of the Study:

By type, the non-ablative segment accounted for the highest market share of 65% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
By region, North America was the major shareholder and accounted for the highest share of 42% in 2018.
By application, the body contouring segment is expected to grow at a CAGR of 14.4% during the forecast period.
By end user, the hospital segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.

Cosmetic lasers is a therapy used to reduce facial wrinkles and skin irregularities, such as skin laxity, moles, liver spots, excess fat, and blemishes or acne scars. The technique directs short, concentrated pulsating beams of light on irregular skin, precisely removing skin layer by layer. This popular procedure is also called lasabrasion, laser peel, or laser vaporization. Cosmetic lasers have revolutionized the beauty industry and offers minimally invasive treatments. Different types of lasers use various wavelength for targeting different pigments. In addition, ablative lasers focus on outer layer of the skin and create micro wounds on the skin surface. Whereas, the non-ablative lasers pass safely through outer skin and breach the tissue lying below.

The report provides a comprehensive analysis of the key players operating in the global cosmetic lasers market are Alma, Candela, Cutera, Cynosure, Deka, Hoyoconbio, Lumensis, Palomar, and Syneron, Aerolase El.En. Spa Lumenis Ltd., Aerolase Corporation Sciton, Inc., Sharp Light Technologies, Fosun Pharmaceutical, Syneron Medical Inc., and Solta Medical. The other players in the value chain include Aerolase Corporation, Iridex, ALLTEC GmbH, and Fotona.

Key Market Segments

By Product
- Ablative Lasers
- Non-Ablative Lasers
By Modality
- Pulsed Dye Laser (PDL)
- YAG Laser
- Carbon Dioxide Laser
- Erbium laser
- Intense Pulsed Light (IPL)
- Radiofrequency
- Infrared
- Others
By Application
- Hair removal
- Scar removal and acne removal
- Skin resurfacing
- Vascular Lesions
- Body Contouring
- Others

Based on cosmetic laser market trend, the body contouring segment dominated the cosmetic laser market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the surge in awareness among individuals toward self-grooming and getting their bodies in shape. Moreover, significant rise in obesity across the globe contributes to the cosmetic laser market growth. Further, body contouring devices are used to tighten lax skin or to remove undesired fat from various body parts, such as waist, abdomen, upper torso, and others. These devices work on different mechanisms such as radiofrequency, cryolipolysis, high-intensity focused ultrasound (HIFU), and others.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5329

Similar Reports:

Breast Biopsy Market

Zika Virus Vaccines Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Infertility Treatment Market is Growing in Asia-Pacific (South Korea, Japan) | Opportunity Analysis and Industry Forecast, 2019–2027

According to a new report published by Allied Market Research, titled, ” Infertility Treatment Market – Global Opportunity Analysis and Industry Forecast, 2019–2027,” The infertility treatment market is expected to grow in upcoming years due to factors such as decline in global fertility rate, increase in number of fertility clinics and hospitals around the world and technological advancements made in the infertility treatment procedure.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐨𝐮𝐜𝐡𝐞𝐫: https://www.alliedmarketresearch.com/request-sample/9870

Infertility is inability of an individual to reproduce by natural way. Infertility is caused due to various reasons. The few reasons include rise in maternal age, disorders related to occurrence of ovulation, tubal occlusion or blockage, sextually transmitted infections, immune infertility, genetics, and infertility caused due to male factors. Treatment options in infertility are to spread awareness, medications for assisting the development during the period of ovulation, In Vitro Fertilization (IVF), Insemination among others.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/9870

COVID-19 scenario analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Considering these factors, COVID -19 is expected to have significant impact on Infertility Treatment Market.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:

This study presents the analytical depiction of the Global Infertility Treatment Market along with the current trends and future estimations to determine the investments.
The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Infertility Treatment Market share.
The current market is quantitatively analyzed from 2020 to 2027 to highlight the Infertility Treatment Market growth scenario.
Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
The report provides a detailed Infertility Treatment Market analysis based on competitive intensity and how the competition will take shape in coming years.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: https://www.alliedmarketresearch.com/request-for-customization/9870

Major players operating in the market include Thermo Fisher Scientific,The Cooper Companies,Cook Group Incorporated,Vitrolife AB,Genea Limited,Esco Micro Pte. Ltd,IVFtech ApS ,The Baker Company,Rocket Medical Plc,Hamilton Throne Ltd, MedGyn Products,ZEISS Group,SoMATEX Medical Technologies GmbH.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Centrifuge Market: https://www.alliedmarketresearch.com/centrifuge-market-A08418

Biopharmaceutical Excipients Market: https://www.alliedmarketresearch.com/biopharmaceutical-excipients-market-A07450

Sleep Apnea Diagnostics Market: https://www.alliedmarketresearch.com/sleep-apnea-diagnostics-market

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Neurostimulation Devices Market 2022 | China to overcome the unmet medical needs boost the demand for neurostimulators

Neurostimulation Devices Market infographics

According to a new report published by Allied Market Research, titled, “Neurostimulation devices Market by device type, application and region: Opportunity Analysis and Industry Forecast, 2019–2026,” the global neurostimulation devices market size is expected to reach $11.2 billion by 2026, registering a CAGR of 12.5% from 2019 to 2026, in terms of value. Neurostimulation functions by altering the pain signals that travel to the brain. Neurostimulation are programmable and implantable devices that deliver electrical stimulation to parts of brain, peripheral nervous system, and spinal cord. These devices are used to treat various medical conditions such as epilepsy, movement disorders, Parkinson’s disease, and chronic pain.

Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/5558

Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are some of the factors that drive the growth of the global neurostimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population further propel the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. The major barriers for the growth of the neurostimulation devices market are side effects such as allergic reaction and tingling or prickling of the skin due to implantation of neurostimulation device into the body and increase in device cost. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.

Key Market Benefits

North America occupied 40.0% share of the global neurostimulation devices market in 2018.
Asia-Pacific is anticipated to grow with the highest CAGR throughout the forecast period.
The spinal cord stimulators segment accounted for 49.9% share of the market in 2018.
The pain management segment is anticipated to grow at the 14.5% during the analysis period.

Comprehensive competitive analysis and profiles of major market players such as Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, NeuroPace Inc., Nevro Corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc.

Key Market Segments

BY APPLICATION
- Pain Management
- Hearing Loss
- Urinary Incontinence
- Parkinson’s Disease
- Epilepsy
- Others
BY DEVICE TYPE
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Others

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5558

Similar Reports:

MRI System Market

Protein Labeling Market

About Us

Medical Display Market 2022 | U.S. are anticipated to fuel the market in North America over the near future

According to a new report published by Allied Market Research, titled, “Medical Display Market, by Device, Panel Size, Resolution, and Application: Opportunity Analysis and Industry Forecast, 2020–2027,” the global medical display market was valued at $2.1 billion in 2019, and is projected to reach $3.2 billion by 2027, registering a CAGR of 4.90% from 2020 to 2027

Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/6069

Key Market Players

ASUSTEK COMPUTER INC
AXIOMTEK CO., LTD
BARCO NV
BENQ MEDICAL TECHNOLOGY
COJE CO., LTD
DELL TECHNOLOGIES INC
DIVA LABORATORIES. LTD
DOUBLE BLACK IMAGING CORPORATION
EIZO CORPORATION
FSN MEDICAL TECHNOLOGIES
NOVANTA INC. (NDS SURGICAL IMAGING)
SONY CORPORATION

The growth of the global medical display market is majorly driven by growth in adoption of hybrid operating rooms, increase in preference for minimally invasive treatments, surging number of medical establishments, and rise in healthcare expenditure across the world. The growth in demand for multimodality displays for radiology and various medical applications to get a detailed view of ultrasound outputs and positron emission tomography (PET) further drive growth of the global medical display market.

COVID-19 Impact

Coronavirus disease (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in a patient, which ranges from common symptoms to serious symptoms. On March 11, 2020, the World Health Organization made an assessment that COVID-19 can be characterized as a pandemic. In addition, no drugs are currently licensed for COVID-19 treatment or prevention. Thus, social distancing is observed as the most important measure to stop spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.

Key Findings Of The Study

By device, the desktop segment was the highest contributor to the market in 2019
On the basis of panel size, the 27.0 to 41.9 inch panels segment dominated the market in 2019, and is expected to continue this trend during forecast period with a CAGR of 5.40%
On the basis of resolution, the above 8MP segment spearheaded the market among other resolution
On the basis of application, the surgical segment held a prominent share in 2019 and is likely to continue its status quo throughout the study period
On the basis of region, Asia-Pacific accounted for the largest share in 2019; and is anticipated to grow at the highest CAGR of 5.70% during the forecast period

Key Market Segments

BY APPLICATION
- Digital pathology
- Multi-modality
- Surgical
- Radiology
- Mammography
- Others
BY PANEL SIZE
- Up to-22.9-inch panels
- 23.0–26.9-inch panels
- 27.0–41.9-inch panels
- Above-42-inch panels

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/6069

Similar Reports:

Extremity Reconstruction Market

Remote Patient Monitoring Market

About Us

Security Information and Event Management Market in Asia: Major Factors that can Increase the Global Demand 2030

An increase in concerns over IT security, the surge in acceptance of BYOD trend, the threat of cybercrimes, and favorable IT governance and law compliance fuel the SIEM market growth in Asia.

On the other hand, the complexity of security information and event management solutions along with the high cost of ownership hinder the market growth.

On the contrary, the emergence of next-generation security information and event management creates opportunities in the market.

Download Sample Report (Get Full Insights in PDF – 211 Pages) at: https://www.alliedmarketresearch.com/request-sample/14373

The report segments the Asia security information and event management market on the basis of deployment model, component, enterprise size, and industry vertical.

Based on component, the solution segment accounted for the largest market share in 2020, contributing to nearly three-fourths of the total share, and is expected to maintain the lead throughout the forecast period. On the other hand, the services segment is estimated to witness the fastest CAGR of 15.4% from 2021 to 2028. The report also covers the regular product type segment.

Based on the deployment model, the on-premise segment contributed to the highest market share in 2020, attributing to around three-fifths of the total market share, and is anticipated to dominate the market during the forecast period. On the other hand, the cloud segment is expected to manifest the fastest CAGR of 15.8% from 2021 to 2028.

Based on region, China contributed to the highest share in 2020, holding more than one-third of the total share, and is anticipated to maintain dominance throughout the forecast period. The Asia SIEM market across India is anticipated to exhibit the fastest CAGR of 20.1% during the forecast period.

List of companies profiled in the Asia security information and event management market analyzed in the research include Dell EMC, Solarwinds Worldwide, LLC, Exabeam, Fortinet, Inc., Micro Focus, RSA Security LLC, IBM Corporation, RAPID7, McAfee LLC, and Splunk, Inc.

COVID-19 scenario:

The COVID-19 pandemic led to the expedited acceptance of the digital transformation journey of the enterprises.
The work-from-home scenario and a stay-at-home norm have motivated technology usage.
The increase in cyber-attacks during the pandemic has created a demand for security information and event management solutions across the markets.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/14373

Thanks for reading this article; you can also get an individual chapter-wise section or region wise report versions like North America, Europe, or Asia.

If you have any special requirements, please let us know and we will offer you the report as per your requirements.

Lastly, this report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

Similar Reports:

Information Technology (IT) Security as a Service Market

2. Crowd Management & Event Security Market

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies. This helps us dig out market data that helps us generate accurate research data tables and confirm utmost accuracy in our market forecasting. Every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll-Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

Alopecia Treatment Market 2022 | Asia-Pacific Region owing to growth in awareness regarding alopecia treatment and rise in adoption of market products

Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, the developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.

According to a new report published by Allied Market Research, titled, “Alopecia Treatment Market by Drug Type, Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2019–2026,” the global alopecia treatment market size was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026.

Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/6310

The alopecia treatment market is expected to experience significant growth during the forecast period, owing to surge in geriatric population; rise in prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis, and others; and increase in prevalence of chemotherapy induced alopecia. In addition, high level of stress, hormonal imbalance, increase in consumption of alcohol & tobacco, and change in food habits further drives the market growth.

Key Findings of the Study:

Based on drug type, the minoxidil segment held more than 44.35% share in the global market in 2018.
By indication, the androgenic alopecia segment accounted for the largest market share in 2018, and is expected to remain dominant throughout the forecast period.
Based on distribution channel, the drug stores & retail pharmacies segment held 58.27% share in the global market in 2018.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.9% during the forecast period.

Key Market Segments

BY DISTRIBUTION CHANNEL
- Hospitals Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
By Indication
- Androgenic Alopecia
- Alopecia Areata
- Alopecia Totalis
- Others
By Drug Type
- Minoxidil
- Finasteride
- Other Drug Types

The key players profiled in this report include Capillus, LLC, Cipla Inc., Daiichi Sankyo Company, Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Transitions Hair, Vitabiotics Ltd., and Vita-Cos-Med Klett-Loch GmbH.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/6310

Similar Reports:

External Defibrillators Market

Prosthetic Heart Valve Market

About Us

Hybrid Operating Room Market New Innovations Trends, Research, Global Share and Growth Factor

Hybrid operating room in medical settings refers to a facility wherein different surgical procedures are performed for the treatment of diverse pathological and physiological conditions in a sterile environment. Hybrid operating room comprises technically efficient and easy-to-use equipment for routine interventions. It is equipped with complex, advanced imaging devices, and supporting technologies that provide a closer & clearer patient diagnosis. The advanced imaging systems assists in minimally invasive procedures, which minimizes the chances of incisions and risk of trauma in patient undergoing treatment. Various clinical applications such as orthopedic trauma surgery, neuronal surgeries, thoracic surgery, cardiovascular surgery, and laparoscopy surgery are performed in the hybrid operating room.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

The key players profiled in this report include Alvo Medical, GE Healthcare, Getinge AB (MAQUET Holding B.V. & Co. KG), Hill-Rom Holdings, Inc. (Trumpf Medical System, Inc.), IMRIS Inc., Koninklijke Philips N.V., Mizuho Corporation, Siemens AG, Stryker Corporation, and Toshiba Corporation (Canon Medical Systems Corporation).

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/6294

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

On the basis of product, the intraoperative diagnostic system segment held 51.32% share in the global market in 2018.
By application, the cardiovascular surgery segment garnered the largest market share in 2018, and is expected to remain dominant throughout the forecast period.
Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 14.2% during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/6294

The major factors that boost the global hybrid operating room market growth are rapid technological advancements in the imaging modalities such as MRI, CT scan, ultrasound, and others; rise in counts of patients undergoing renal, cardiac, oncological, and neurological treatments; and increase in preference of patients toward hybrid operating room due to better patient safety, shorter hospital stays, and accurate diagnosis & treatment. In addition, surge in investment in hybrid OR equipment, growth in regulatory approvals for different hybrid operating equipment, increase in patient preference for effective & affordable surgical treatment are expected to boost the market growth during the forecast period. However, low income and lack of proper medical attention in the developing countries hamper the growth of the hybrid operating room market.

𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/hybrid-operating-room-market

Depending on product, the market is divided into magnetic resonance imaging (MRI), computed tomography (CT), angiography systems, and others. The intraoperative diagnostic system segment dominated the hybrid operating room market in 2018, due to technological advancements in intraoperative diagnostic systems, surge in prevalence of chronic diseases along with changes in lifestyle, and rise in demand for innovative & hybrid operating room equipment.

By application, the cardiovascular surgery segment was the highest revenue contributor in the hybrid operating room market in 2018, and is expected to maintain its dominance during the forecast period. This is attributed to rise in incidence & prevalence of cardiovascular surgery diseases, and increase in adoption of endovascular procedures during cardiovascular surgeries. In addition, surge in demand for minimally invasive surgeries and increase in number of patients suffering from obesity are expected to offer remunerative opportunities for market expansion in the near future.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Bronchoscopy Market

Indian Glaucoma and Cataract Surgery Devices Market

About Us

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Japan Protein Expression Market Growth Driven by significantly investing in R&D expenditure by pharmaceutical companies

According to a new report published by Allied Market Research, titled, “Global Protein Expression Market by product (reagents, expression vectors, competent cells, instruments, services), by application (therapeutic, industrial, research): Opportunity Analysis and Industry Forecast, 2018–2026,” the global protein expression market is expected to reach $4 billion by 2026, registering a CAGR of 10.2% from 2018 to 2026, in terms of value.

Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/6463

Key Market Players

AGILENT TECHNOLOGIES, INC.
BECTON, DICKINSON AND COMPANY
BIO-RAD LABORATORIES, INC.
GenScript Biotech Corporation
LifeSensors Inc.
Merck KGaA
Promega Corporation
QIAGEN N.V.
Takara Holdings Inc.
THERMO FISHER SCIENTIFIC, INC.

Protein expression is defined as a biotechnological procedure, which includes generation of precise proteins. These proteins are formed through manipulation of gene expression in organisms of interest. The procedure leads to expression of large amounts of recombinant gene in organisms. Furthermore, this has led to many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. This, in turn, has led to advancements in genetic engineering and recombinant technologies. Significant advancements in the field of biotechnology have enabled expression and isolation of recombinant proteins on large scale. Some of products which are used to perform protein expression present in the market include reagents, expression vectors, competent cells, instruments, and others. These products are used in designing therapeutics and conducting research related to medicines.

The factors that boost the growth of the protein expression market include surge in geriatric population and increase in prevalence of chronic diseases such as cancer. Moreover, increase in spending on protein research also fuel the growth of the protein expression market. However, high monetary inputs associated with the production of protein products restrict the growth of the market. In addition, significant shortage of trained healthcare professionals and lack of local expertise also restrains the market. Conversely, emergence of microfluids, along with growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

Key Findings of the Study:

Based on product, the reagents accounted for a share of nearly 54.4% in the protein expression market in 2018.
Based on region, the Asia-Pacific segment is anticipated to grow with the highest CAGR of 11.20% throughout the forecast period.
Europe accounted 32.10% of the global protein expression market in 2018.

Key Market Segments

By Product
- Reagents
- Expression vectors
- Competent cells
- Instruments
- Services
By Application
- Therapeutic
- Industrial
- Research

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/6463

Similar Reports:

Biomaterials Market

Asthma and COPD Drugs Market

About Us

Immunosuppressants Market 2026 – Korea is Expected to Dominate the Market in Near Future

The global immunosuppressants market size was valued at $13,890 million in 2018 and is expected to reach $42,511 million by 2026, registering a CAGR of 14.7% from 2019 to 2026. Immunosuppressants are the drugs that are administered to minimize the chances of organ rejection after transplantation. For almost every individual who receives an organ transplant, immunosuppressants are a must to be taken. This is because immune system reacts to transplanted organs as foreign objects and develops an immune response against it, thereby, destroying the organ and at the same time affect other body parts as well. These drugs prevent hyper immune response of a patient’s body. These drugs are also widely used by patients suffering from auto-immune disorders such as Chron’s disease, irritable bowel disease, and arthritis.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

Comprehensive competitive analysis and profiles of major market players such as Astellas Pharma, Inc., Bristol Myers Squibb, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc., Intas Pharmaceuticals Ltd., Johnson & Johnson, Mylan Laboratories Inc., Novartis AG, Pfizer, Inc., Sanofi S.A. are provided in this report.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/6288

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By drug class, the calcineurin inhibitors segment accounted for the highest market share of 35% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
By region, North America was the major shareholder and accounted for the highest share of 42% in 2018.
By indication, auto-immune disorder segment is expected to grow at a CAGR of 13.6% during the forecast period.
By distribution channel, the hospital pharmacy segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/6288

Significant increase in the incidence of autoimmune disorders including arthritis and multiple sclerosis and rise in adoption of organ donation among individuals are the major factors that drive the immunosuppressant market growth. In addition, surge in government initiatives towards developing programmes for raising awareness related o organ transplantation propels the market growth. For instance, according to European National Health Service (NHS) in 2018, the U.K. government announced the introduction of new plans to change the law for organ and tissue donation to address urgent unmet need for organs within Indian-origin communities in the country. However, high cost of immunosuppressant drugs and side effects associated with them such as diarrhoea, higher susceptibility to infection, nausea, and vomiting are expected to hamper the growth of immunosuppressants market. On the contrary, the increase in use of tissue engineering for generation of implants provides growth opportunities to the immunosuppressant market trends. In addition, rise in disposable income in developing economies and surge in awareness among individuals toward organ donation is anticipated to create lucrative opportunities in the near future.

𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/immunosuppressants-market

By drug class, the calcineurin inhibitors segment accounted for majority of the immunosuppressants market share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to the fact that it is the most used immunosuppressant drug used after organ transplantation to suppress hyper immune response. The most widely prescribed calcineurin inhibitors drugs include cyclosporine and tacrolimus. This segment is also anticipated to be the fastest growing drug class segment during the forecast period.

By indication, the auto-immune disorder segment dominated the immunosuppressants market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the surge incidence of auto immune disorders across the globe. For instance, according to national institute of environmental health sciences (NIH), autoimmune diseases are among the most prevalent diseases in the U.S., affecting more than 23.5 million Americans.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Single-arm Medical Pendant Market

Orthobiologics Market

About Us

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

Mobile Gamma Cameras Market New Opportunities, Top Trends, Rising Demand, Emerging Growth, Business Development

Mobile gamma cameras market size was $58 million in 2018, and is projected to reach $82 million by 2026, growing at a CAGR of 4.7% from 2019 to 2026. The single-head mobile gamma cameras segment accounted more than two-third of the total mobile gamma cameras market share in 2018.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

The report provides a comprehensive analysis of the key players operating in the global mobile gamma cameras market industry, namely, Dilon Technologies, Inc, General Electric Company (GE Healthcare), Digirad Corporation, DDD-Diagnostic A/S, GAEDE Medizinsysteme GmbH, Adolesco AB, MiE GmbH, Gamma Medica, Inc., Crystal Photonics GmbH, and Oncovision.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/5645

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

Based on product type, the single-head mobile gamma cameras segment was the major revenue contributor in 2018 and is anticipated to continue this trend during the forecast period.
Based on application segment, its intraoperative imaging segment is expected to exhibit the highest CAGR with 6.2% during the forecast period.
Depending on end user, the hospital segment was the largest revenue contributor in 2018 and is expected to continue this trend from 2019 to 2026.
U.S. generated the highest revenue in the global mobile gamma cameras market in 2018, accounting for more than two-fifth of the global market in 2018.
Asia Pacific is estimated to grow at the highest CAGR during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/5645

The mobile gamma cameras market is expected to exhibit significant growth during the forecast period due to the technological advancements in expanding the imaging options and advantages of mobile gamma cameras over traditional gamma cameras. Further, rise in prevalence of chronic diseases in near future are the factors fueling the growth of the global market. However, decline in organ function, hair loss and skin burn of mobile gamma cameras and exposure to a lethal dose of gamma radiation are the factors that hinder the growth of the global mobile gamma cameras market. On the contrary, hybrid or multimodal approaches can help overcome individual weaknesses, which result in advancement of the field of interventional molecular imaging and image-guided surgery.

Based on product type, the market is categorized into single-head mobile gamma cameras, dual-head mobile gamma cameras, triple-head mobile gamma cameras and handheld mobile gamma camera. The triple-head mobile gamma cameras segment is projected to exhibit the highest growth during the forecast period. This is attributed to the superior quality of the obtained images and increase in incidences of chronic diseases.

𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/mobile-gamma-cameras-market

North America was the leading revenue contributor to the global mobile gamma cameras market in 2018, and is expected to remain dominant throughout the forecast period. This is attributed to upsurge in incidence of chronic diseases, rise in technological advancements of mobile gamma camera, its nature of non- invasive detection, availability of portable mobile gamma camera, and its high purchasing power.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Topical Pain Relief Market

Orthobiologics Market

About Us

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact: